The neuropathological basis of clinical progression in multiple sclerosis
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Richard Reynolds Federico Roncaroli Richard Nicholas Bishan Radotra Djordje Gveric Owain Howell
- چاپ و سال / کشور: 2011
Description
Multiple sclerosis is the major inflammatory condition affecting the central nervous system (CNS) and is characterised by disseminated focal immune-mediated demyelination. Demyelination is accompanied by variable axonal damage and loss and reactive gliosis. It is this pathology that is thought to be responsible for the clinical relapses that often respond well to immunomodulatory therapy. However, the later secondary progressive stage of MS remains largely refractory to treatment and it is widely suggested that accumulating axon loss is responsible for clinical progression. Although initially thought to be a white matter (WM) disease, it is increasingly apparent that extensive pathology is also seen in the grey matter (GM) throughout the CNS. GM pathology is characterised by demyelination in the relative absence of an immune cell infiltrate. Neuronal loss is also seen both in the GM lesions and in unaffected areas of the GM. The slow progressive nature of this later stage combined with the presence of extensive grey matter pathology has led to the suggestion that neurodegeneration might play an increasing role with increasing disease duration. However, there is a paucity of studies that have correlated the pathological features with clinical milestones during secondary progressive MS. Here, we review the contributions that the various types of pathology are likely to make to the increasing neurological deficit in MS.
Acta Neuropathol (2011) 122:155–170 DOI 10.1007/s00401-011-0840-0 Received: 30 April 2011 / Accepted: 18 May 2011 / Published online: 28 May 2011
